Publication | Open Access
Comparable efficacy and safety of dimethyl fumarate and teriflunomide treatment in Relapsing-Remitting Multiple Sclerosis: an Italian real-word multicenter experience
38
Citations
18
References
2018
Year
DMF and TRF significantly impacted RRMS disease activity in our study. Serious safety concerns were recorded in less than 2% of the studied population.
| Year | Citations | |
|---|---|---|
Page 1
Page 1